How big is the Infused Drugs Market?

The Infused Drugs Market size is expected to reach USD 8.5 billion in 2024 and grow at a CAGR of 7.30% to reach USD 11.5 billion by 2029. Read More

What is the current Infused Drugs Market size?

In 2024, the Infused Drugs Market size is expected to reach USD 8.5 billion. Read More

Who are the key players in Infused Drugs Market?

AstraZeneca, Sanofi SA, Bristol-Myers Squibb Company, Amgen, Inc. and Teva Pharmaceutical Industries Ltd. are the major companies operating in the Infused Drugs Market. Read More

Which is the fastest growing region in Infused Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Infused Drugs Market?

In 2024, the North America accounts for the largest market share in Infused Drugs Market. Read More

What years does this Infused Drugs Market cover, and what was the market size in 2023?

In 2023, the Infused Drugs Market size was estimated at USD 7.88 billion. The report covers the Infused Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Infused Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Infused Drugs Market Size & Share Analysis - Industry Research Report

Infused Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Infused Drugs Market Report is Segmented by Drug (Small Molecules and Biologics), Therapeutic Area (Oncology, Gastrointestinal Diseases, Rheumatoid Arthritis, Immune Deficiencies, Cardiology, Neurology, Diabetes, and Other Therapeutic Areas), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value in USD for the Above Segments.

Infused Drugs Industry Overview

The infused drugs market is moderately competitive. The key players are adopting various strategies such as product launches, expansion of the products and services into new regions, mergers, acquisitions, and entering new partnerships and collaborations to strengthen their position in the market. The key players include AstraZeneca, Sanofi SA, Teva Pharmaceutical Industries Ltd, Amgen, Inc., and Bristol-Myers Squibb Company.